Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zambon sa-nv - acetylcysteine 200 mg - granules for oral solution - 200 mg - acetylcysteine 200 mg - acetylcysteine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zambon sa-nv - acetylcysteine 600 mg - granules for oral solution - 600 mg - acetylcysteine 600 mg - acetylcysteine

United States - English - NLM (National Library of Medicine)

advanced rx pharmacy of tennessee, llc - docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag), sennosides a and b (unii: 1b5fpi42en) (sennosides a and b - unii:1b5fpi42en) - purposes stool softener laxative uses - relieves occasional constipation (irregularity) - generally produces a bowel movement in 6-12 hours do not use - if you are now taking mineral oil, unless directed by a doctor - laxative products for longer than 1 week unless directed by a doctor stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. these may indicate a serious condition.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium husk powder, quantity: 534.7 mg/g - powder, oral - excipient ingredients: maltodextrin; citric acid; aspartame; quinoline yellow; sunset yellow fcf; flavour - metamucil indicated in the management of chronic constipation, constipation in irritable bowel syndrome, as adjunctive therapy in diverticular diease and constipation caused by antacid used in duodenal ulcer; in the bowel management of patients with haemorroids, and for constipation during pregnancy, convalescence, and senility.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 581.2 mg/g - powder, oral - excipient ingredients: maltodextrin; citric acid; quinoline yellow; sunset yellow fcf; aspartame; flavour - metamucil is indicated in the management of chronic constipation, constipation in irritable bowel syndrome, as adjunctive therapy in diverticular disease and constipation caused by antacid used in duodenal ulcer; in the bowel management of patients with haemorrhoids and for constipation during pregnancy, convalescence and senility.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 0.3128 g/g - powder - excipient ingredients: sucrose; citric acid; sunset yellow fcf; flavour - metamucil is indicated in the management of chronic constipation, constipation in irritable bowel guidance, as adjunctive therapy in diverticular disease and constipation caused by antacid used in duodenal ucler; in the bowel management of patients with haemorrhoids and for constipation during pregnancy, convalescence, and senility.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 0.5618 g/g - powder - excipient ingredients: maltodextrin; citric acid; aspartame; sunset yellow fcf - metamucil is indicated in the management of chronic constipation, constipation in irritable bowel guidance, as adjunctive therapy in diverticular disease and constipation caused by antacid used in duodenal ulcer; in the bowel management of patients with haemorrhoids and for constipation during pregnancy, convalescence, and senility.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 0.5618 g/g - powder - excipient ingredients: maltodextrin; citric acid; aspartame; sunset yellow fcf; flavour - metamucil is indicated in the management of chronic constipation, constipation in irritable bowel guidance, as adjunctive therapy in diverticular disease and constipation caused by antacid used in duodenal ulcer; in the bowel management of patients with haemorrhoids and for constipation during pregnancy, convalescence, and senility.

Australia - English - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - psyllium husk powder, quantity: 568 mg/g - oral liquid, powder for - excipient ingredients: brilliant blue fcf; allura red ac; citric acid; malic acid; aspartame; maltodextrin; acesulfame potassium; flavour - management of chronic constipation; constipation in irritable bowel syndrome; as adjunctive therapy in diverticular disease; in the bowel management of patients with haemorrhoids; and for constipation during pregnancy, convalescence and senility. diets low in saturated fat and cholesterol that include 7 grams of soluble fibre from psyllium husk, as in metamucil, may lower cholesterol levels. reductions in cholesterol may contribute to reducing the risk of heart disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

proqualix pty ltd - in administration - psyllium hydrophilic mucilloid, quantity: 0.56 g/g - powder, oral - excipient ingredients: sodium bicarbonate; sucrose; saccharin sodium; potassium bicarbonate; sunset yellow fcf; flavour - indications for: malaysia and singapore metamucil is indicated in the management of chronic constipations, constipation in irritable bowel syndrome, as adjunctive therapy in diverticulr disease and constipation caused by antacid use in duodenal ulcer; in the bowel management of patients with haemorroids, and for constipation during pregnancy, convalescence and senility